Morning Movers 3/25: BKRS, NIV, TRIT, GIII, CRXX, CONN Higher; ABK, MAIL, MELA, UTIW Lower
Bakers Footwear Group Inc. (NASDAQ: BKRS) 60% HIGHER; reports Q4 EPS of $0.73, versus $0.07 reported for the same period a year ago. Revenue for the quarter was $57.6 million, compared to $55.5 million in Q408. Comps up 2.3%.
NIVS IntelliMedia Technology Group, Inc. (NYSE: NIV) 26.4% HIGHER; reports Q4 EPS of $0.28, versus $0.04 reported for the same period a year ago. Revenue for the quarter was $62.7 million, compared to $42.6 million in Q408.
Ambac (NYSE: ABK) 26.2% LOWER; disclosed that it is looking to negotiate a restructuring of its debt through a prepackaged bankruptcy proceeding.
IncrediMail, Ltd. (NASDAQ: MAIL) 24.3% LOWER; reports Q4 EPS of $0.21, versus $0.47 reported for the same period a year ago. Revenue for the quarter was $7.47 million, compared to $6.07 million in Q408.
MELA Sciences (NASDAQ: MELA) 23.9% LOWER; today announced that it has received additional questions from U.S. FDA regarding the review status of the Pre-Market Approval application of its MelaFind device for early melanoma detection. The company is actively working to respond to the agency's questions in the immediate term. The FDA indicated that the MelaFind PMA review has been extended 180 days. Click here to see the full report.
Tri-Tech Holding, Inc. (NASDAQ: TRIT) 18.6% HIGHER; reports Q4 EPS of $0.24, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $5.9 million, compared to $2.9 million in Q408.
G-III Apparel Group, Ltd. (NASDAQ: GIII) 15.4% HIGHER; reports Q4 EPS of $0.40, versus the analyst estimate of $0.02. Revenue for the quarter was $193.8 million, which compares to the estimate of $174.75 million. Sees Q110 sales of $135 million, and a loss of $0.18 - $0.23. Consensus sees sales of $123.64 million, and a loss of $0.34.
CombinatoRx, Incorporated (Nasdaq: CRXX) 15.4% HIGHER; reports Q4 EPS of $0.57, versus a loss of $0.43 reported for the same period a year ago. Revenue for the quarter was $8.58 million, compared to $3.46 million in Q408.
Conn's, Inc. (NASDAQ: CONN) 14.5% HIGHER; reports Q4 adjusted EPS of $0.08, 5 cents better than the analyst estimate of $0.03. Revenue for the quarter was $202.3 million, which compares to the estimate of $196.20 million.
The Quigley Corporation (NASDAQ: QGLY) 13.5% HIGHER; reports Q4 EPS of $0.14, versus the analyst estimate of ($0.01). Revenue for the quarter was $9.1 million, which compares to the estimate of $5.32 million.
Star Scientific, Inc. (Nasdaq: CIGX) 12.9% HIGHER; a 13G was filed from Iroquois Capital Management disclosing a 7.6%, or 8,738,872 share, stake in the company.
Lululemon Athletica, Inc. (NASDAQ: LULU) 12.8% HIGHER; reports Q4 EPS of $0.40, 11 cents better than the analyst estimate of $0.29. Revenue for the quarter was $160.6 million, which compares to the estimate of $143.54 million. Sees Q110 sales 125 - 130 million, versus $109.8 million consensus. Also sees Q110 EPS of $0.18 - $0.20, versus $0.17 consensus. Sees FY10 EPS of $1.00 - $1.05, versus the consensus of $0.96. Also Sees FY10 sales of $570 - $585 million, versus the consensus of $532 million.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) 11.7% HIGHER; today announced the European approval of ondansetron RapidFilm, co-developed by APR Applied Pharma Research s.a., and Labtec GmbH and licensed to BioAlliance Pharma s.a. for European Union countries. Click here for the full report.
Anika Therapeutics (Nasdaq: ANIK) 11% HIGHER; technicians are buying the stock today amid a breakout over the $7 level. The stock has not traded over $7 since very early in January.
OMNOVA Solutions Inc. (NYSE: OMN) 10.8% HIGHER; reports Q1 GAAP EPS of $0.17 which may not compare to the analyst estimate of $0.10. Revenue for the quarter was $183.9 million, which compares to the estimate of $179 million.
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) 9.9% HIGHER; today announced the U.S. FDA has granted marketing approval for XIFAXAN(R) (rifaximin) 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older.
UTI Worldwide, Inc. (NASDAQ: UTIW) 9.7% LOWER; reports Q4 adjusted EPS of $0.11, versus the analyst estimate of $0.16. Revenue for the quarter was $991.5 million, which compares to the estimate of $924.10 million. The stock was also downgraded at Jesup & Lamont.
Qualcomm Incorporated (Nasdaq: QCOM) 8.9% HIGHER; Raises quarterly sales guidance from $2.40-$2.60 billion to $2.55-$2.65 billion, vs. the consensus of $2.58 billion. Raises its EPS outlook from $0.42-$0.44 to $0.56-$0.58, which compares to the Street estimate of $0.52.
SunLink Health Systems (AMEX: SSY) 8.4% LOWER; correcting today following a more than 100% rise over the last three trading sessions.
PFSweb Inc. (NASDAQ: PFSW) 8.2% LOWER; reports Q4 non-GAAP loss of $0.08, versus $0.04 reported for the same period a year ago. Revenue for the quarter was $95.6 million, compared to $112.8 million in Q408.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
NIVS IntelliMedia Technology Group, Inc. (NYSE: NIV) 26.4% HIGHER; reports Q4 EPS of $0.28, versus $0.04 reported for the same period a year ago. Revenue for the quarter was $62.7 million, compared to $42.6 million in Q408.
Ambac (NYSE: ABK) 26.2% LOWER; disclosed that it is looking to negotiate a restructuring of its debt through a prepackaged bankruptcy proceeding.
IncrediMail, Ltd. (NASDAQ: MAIL) 24.3% LOWER; reports Q4 EPS of $0.21, versus $0.47 reported for the same period a year ago. Revenue for the quarter was $7.47 million, compared to $6.07 million in Q408.
MELA Sciences (NASDAQ: MELA) 23.9% LOWER; today announced that it has received additional questions from U.S. FDA regarding the review status of the Pre-Market Approval application of its MelaFind device for early melanoma detection. The company is actively working to respond to the agency's questions in the immediate term. The FDA indicated that the MelaFind PMA review has been extended 180 days. Click here to see the full report.
Tri-Tech Holding, Inc. (NASDAQ: TRIT) 18.6% HIGHER; reports Q4 EPS of $0.24, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $5.9 million, compared to $2.9 million in Q408.
G-III Apparel Group, Ltd. (NASDAQ: GIII) 15.4% HIGHER; reports Q4 EPS of $0.40, versus the analyst estimate of $0.02. Revenue for the quarter was $193.8 million, which compares to the estimate of $174.75 million. Sees Q110 sales of $135 million, and a loss of $0.18 - $0.23. Consensus sees sales of $123.64 million, and a loss of $0.34.
CombinatoRx, Incorporated (Nasdaq: CRXX) 15.4% HIGHER; reports Q4 EPS of $0.57, versus a loss of $0.43 reported for the same period a year ago. Revenue for the quarter was $8.58 million, compared to $3.46 million in Q408.
Conn's, Inc. (NASDAQ: CONN) 14.5% HIGHER; reports Q4 adjusted EPS of $0.08, 5 cents better than the analyst estimate of $0.03. Revenue for the quarter was $202.3 million, which compares to the estimate of $196.20 million.
The Quigley Corporation (NASDAQ: QGLY) 13.5% HIGHER; reports Q4 EPS of $0.14, versus the analyst estimate of ($0.01). Revenue for the quarter was $9.1 million, which compares to the estimate of $5.32 million.
Star Scientific, Inc. (Nasdaq: CIGX) 12.9% HIGHER; a 13G was filed from Iroquois Capital Management disclosing a 7.6%, or 8,738,872 share, stake in the company.
Lululemon Athletica, Inc. (NASDAQ: LULU) 12.8% HIGHER; reports Q4 EPS of $0.40, 11 cents better than the analyst estimate of $0.29. Revenue for the quarter was $160.6 million, which compares to the estimate of $143.54 million. Sees Q110 sales 125 - 130 million, versus $109.8 million consensus. Also sees Q110 EPS of $0.18 - $0.20, versus $0.17 consensus. Sees FY10 EPS of $1.00 - $1.05, versus the consensus of $0.96. Also Sees FY10 sales of $570 - $585 million, versus the consensus of $532 million.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) 11.7% HIGHER; today announced the European approval of ondansetron RapidFilm, co-developed by APR Applied Pharma Research s.a., and Labtec GmbH and licensed to BioAlliance Pharma s.a. for European Union countries. Click here for the full report.
Anika Therapeutics (Nasdaq: ANIK) 11% HIGHER; technicians are buying the stock today amid a breakout over the $7 level. The stock has not traded over $7 since very early in January.
OMNOVA Solutions Inc. (NYSE: OMN) 10.8% HIGHER; reports Q1 GAAP EPS of $0.17 which may not compare to the analyst estimate of $0.10. Revenue for the quarter was $183.9 million, which compares to the estimate of $179 million.
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) 9.9% HIGHER; today announced the U.S. FDA has granted marketing approval for XIFAXAN(R) (rifaximin) 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older.
UTI Worldwide, Inc. (NASDAQ: UTIW) 9.7% LOWER; reports Q4 adjusted EPS of $0.11, versus the analyst estimate of $0.16. Revenue for the quarter was $991.5 million, which compares to the estimate of $924.10 million. The stock was also downgraded at Jesup & Lamont.
Qualcomm Incorporated (Nasdaq: QCOM) 8.9% HIGHER; Raises quarterly sales guidance from $2.40-$2.60 billion to $2.55-$2.65 billion, vs. the consensus of $2.58 billion. Raises its EPS outlook from $0.42-$0.44 to $0.56-$0.58, which compares to the Street estimate of $0.52.
SunLink Health Systems (AMEX: SSY) 8.4% LOWER; correcting today following a more than 100% rise over the last three trading sessions.
PFSweb Inc. (NASDAQ: PFSW) 8.2% LOWER; reports Q4 non-GAAP loss of $0.08, versus $0.04 reported for the same period a year ago. Revenue for the quarter was $95.6 million, compared to $112.8 million in Q408.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
You May Also Be Interested In
- Notable Analyst Rating Changes 05/25: (CRM) (EMN) (ITW) Upgraded; (HNZ) (COG) (LULU) Downgraded
- Trading Radar for 05/29: Eltek (ELTK), Sanderson Farms (SAFM), Chimera Investment (CIM), Cavco Industries (CVCO) Report
- Unusual 11 Mid-Day Movers 05/23: (SCHS) (AMBT) (PCX) Higher; (DELL) (EGLE) (GENE) Lower
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Jesup & Lamont, Morning Movers, Bankruptcy, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
